Marijuana startup MassRoots' plans to join Nasdaq go up in smoke

Marijuana startup MassRoots' plans to join Nasdaq go up in smoke
Nasdaq listing snub could set a precedent for marijuana stocks.
MAY 26, 2016
MassRoots, an online social network for marijuana fans, experienced a massive downer Monday when the NASDAQ exchange denied its listing request based on the fact cannabis is still illegal at the federal level. According to a statement from MassRoots, a company that is currently trading over the counter, the exchange request was denied due to concerns over aiding and abetting the distribution of an illegal substance. “With this decision, the Nasdaq has set a dangerous precedent that will prevent nearly every company in the regulated cannabis industry from listing on a national exchange,” said MassRoots chief executive Isaac Dietrich in a prepared statement. “This will have ripple effects across the entire industry, making it more difficult for cannabis entrepreneurs to raise capital and slow the progression of cannabis legalization in the United States,” he added. “This decision must not be allowed to stand and we're asking every cannabis investor, business, activist and supporter to write a brief note to the Nasdaq in support of our appeal here.” MassRoots, which applied for the listing in early April, plans to appeal the exchange's decision. MassRoots was also planning a reverse stock split if it was listed on the exchange. The stock is trading at 90 cents a share, down 42.7% from April 11 when it applied to be listed on the exchange. The stock is down 18.2% since the start of the year. The S&P 500 Index is flat from April 11, and up 1.1% since the start of the year. So far, 40 states have legalized the use of medical marijuana in some form, and four have legalized marijuana for recreational use. Even though the Department of Justice has extended for a second year through the end of 2016 a “cease fire” of federal marijuana-law enforcement over state laws, those states are still in technical violation of federal law. That is the kind of reality that has a lot of financial advisers placing pot stocks on the extreme end of the risk curve.

Latest News

Carnegie Investment Counsel sued over valuation suppression
Carnegie Investment Counsel sued over valuation suppression

Retiring RIA seller David Laidlaw alleges the Carnegie valued his stake on $11.7 million EBITA while pitching potential buyers on $21.3 million.

Arch pushes AI portfolio monitoring into pre-investment due diligence
Arch pushes AI portfolio monitoring into pre-investment due diligence

New tool gives RIAs and family offices AI help vetting private market deals, with some users reportedly halving review time.

$4.5M raised on trust alone: SEC alleges affinity fraud in merchant lending
$4.5M raised on trust alone: SEC alleges affinity fraud in merchant lending

Investors got projected returns dressed up as real ones, SEC says

Treasury sets auto-enrollment rules for Trump Accounts, potentially adding 60 million more children
Treasury sets auto-enrollment rules for Trump Accounts, potentially adding 60 million more children

Parents must still act to get the $1,000 federal seed and employer contributions, giving financial advisors a role in the rollout.

FINRA bars former LPL broker for stealing $1.7 million from customers
FINRA bars former LPL broker for stealing $1.7 million from customers

FINRA booted Rudy Anguiano from the industry for “conversion - the intentional and unauthorized taking of another person’s property.”

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor

SPONSORED Direct indexing webinar targets tax-loss harvesting amid market swings

Northern Trust’s Ken Lassner shows advisors how to convert volatility into after-tax portfolio gains